ANTHONY THOMPSON: Open Payments
NPI 1144936048 · NORTH DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 37 payments from 12 companies in 2025. Trend: 2023 $792 · 2024 $439 · 2025 $699
Food & beverage: $699
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $143 |
| Vanda Pharmaceuticals Inc. | 5 | $107 |
| Alkermes, Inc. | 4 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| Supernus Pharmaceuticals, Inc. | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Sage Therapeutics, LLC | 1 | $18 |
Products named: VRAYLAR, REXULTI, FANAPT, ARISTADA, Qelbree, AUSTEDO XR, CAPLYTA, INVEGA SUSTENNA.
Industry payments across MA — which companies pay providers there.
